Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Teva
AstraZeneca
Harvard Business School
Covington
Chubb
McKinsey
US Department of Justice
Daiichi Sankyo

Generated: February 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Anlotinib

« Back to Dashboard

US Patents for Anlotinib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Anlotinib ➤ Sign Up Spiro substituted compounds as angiogenesis inhibitors ➤ Sign Up
Anlotinib ➤ Sign Up Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts Advenchen Pharmaceuticals, LLC (Moorpark, CA) ➤ Sign Up
Anlotinib ➤ Sign Up Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same Advenchen Laboratories Nanjing Ltd (Jiangsu, CN) Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Jiangsu, CN) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Anlotinib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Anlotinib Australia 2008226666 2027-03-14 ➤ Sign Up
Anlotinib Brazil PI0805826 2027-03-14 ➤ Sign Up
Anlotinib Canada 2709220 2027-03-14 ➤ Sign Up
Anlotinib China 101809012 2027-03-14 ➤ Sign Up
Anlotinib China 103467454 2027-03-14 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Harvard Business School
UBS
Julphar
Chinese Patent Office
Federal Trade Commission
Deloitte
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: